In this large population-based cohort study from the UK Biobank, we investigated independent and combined associations of plasma NfL and GFAP levels with future incident diagnoses of several major neurodegenerative diseases to shed light on the usefulness of these biomarkers in this challenging scenario. Here, NEFL is linked to neurodegenerative disease.